Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LDB1 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | FES | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | TAL1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | BAHCC1 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | MB21D1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | OR51V1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | NARF | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | RPL3 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
mRNA | SSBP4 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | DENND5A | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |